logo
Apple CEO Tells Staff AI Is ‘Ours to Grab' in Hourlong Pep Talk

Apple CEO Tells Staff AI Is ‘Ours to Grab' in Hourlong Pep Talk

Yahoo17 hours ago
(Bloomberg) -- Apple Inc. Chief Executive Officer Tim Cook, holding a rare all-hands meeting following earnings results, rallied employees around the company's artificial intelligence prospects and an 'amazing' pipeline of products.
The World's Data Center Capital Has Residents Surrounded
An Abandoned Art-Deco Landmark in Buffalo Awaits Revival
We Should All Be Biking Along the Beach
Budapest's Most Historic Site Gets a Controversial Rebuild
San Francisco in Talks With Vanderbilt for Downtown Campus
The executive gathered staff at Apple's on-campus auditorium Friday in Cupertino, California, telling them that the AI revolution is 'as big or bigger' as the internet, smartphones, cloud computing and apps. 'Apple must do this. Apple will do this. This is sort of ours to grab,' Cook told employees, according to people aware of the meeting. 'We will make the investment to do it.'
The iPhone maker has been late to AI, debuting Apple Intelligence months after OpenAI, Alphabet Inc.'s Google, Microsoft Corp. and others flooded the market with products like ChatGPT. And when Apple finally released its AI tools, they fell flat.
But Cook struck an optimistic tone, noting that Apple is typically late to promising new technologies.
'We've rarely been first,' the executive told staffers. 'There was a PC before the Mac; there was a smartphone before the iPhone; there were many tablets before the iPad; there was an MP3 player before iPod.'
But Apple invented the 'modern' versions of those product categories, he said. 'This is how I feel about AI.'
An Apple spokesperson declined to comment on the gathering.
The hourlong meeting addressed a range of topics, including the retirement of operating chief Jeff Williams, increasing Apple TV+ viewership and advances in health care with features like the AirPods Pro hearing-aid technology. It also touched on donations and community service by Apple employees, the company's goal to become carbon neutral by 2030, and the impact of regulations.
'The reality is that Big Tech is under a lot of scrutiny around the world,' Cook said. 'We need to continue to push on the intention of the regulation and get them to offer that up, instead of these things that destroy the user experience and user privacy and security.'
Cook often holds town hall-style chats when visiting Apple's offices around the world, but companywide meetings from the Steve Jobs Theater at headquarters are unusual.
The remarks followed a blockbuster earnings report, with sales growing nearly 10% during the June quarter. That beat Wall Street expectations and eased concerns about iPhone demand and a slowdown in China.
Apple still faces myriad challenges, including Trump administration tariffs and a regulatory crackdown on its business practices. The company said Thursday that tariffs would bring a $1.1 billion headwind this quarter, though Apple was upbeat about sales growth. It also said that App Store revenue rose by a percentage in the double digits last quarter, despite efforts in the EU and elsewhere to further restrict that business.
Echoing comments he made during the earnings conference call, Cook told employees the company is investing in AI in a 'big way.' He said 12,000 workers were hired in the last year, with 40% of the new hires joining in research and development roles.
Apple's chip development efforts, led by executive Johny Srouji, are key to the company's AI strategy, Cook said. Apple is working on a more powerful cloud-computing chip — code-named Baltra — to power artificial intelligence features, Bloomberg News has reported. It's also setting up a new AI server manufacturing facility in Houston.
The meeting included Craig Federighi, senior vice president of software engineering, who discussed the future of Apple's Siri voice assistant. The company had planned to roll out a Siri overhaul as part of Apple Intelligence earlier this year, adding the ability to tap into user data to better fulfill requests. It was delayed, spurring management changes for the company's AI work.
Federighi explained that the problem was caused by trying to roll out a version of Siri that merged two different systems: one for handling current commands — like setting timers — and another based on large language models, the software behind generative AI. 'We initially wanted to do a hybrid architecture, but we realized that approach wasn't going to get us to Apple quality,' Federighi said.
Now, Apple is working on a version of Siri that moves to an entirely new architecture for all of its capabilities. That iteration is slated for as early as spring, Bloomberg News has reported, though Apple executives haven't confirmed a timeline other than a release next year.
'The work we've done on this end-to-end revamp of Siri has given us the results we needed,' the engineering executive told employees. 'This has put us in a position to not just deliver what we announced, but to deliver a much bigger upgrade than we envisioned. There is no project people are taking more seriously.'
Federighi cited leadership changes, including putting Vision Pro creator Mike Rockwell and his headset software leadership team in charge of Siri, as a driving force in improving the product. He said Rockwell and his group have 'supercharged' the company's work in the area.
In his speech, Cook also pushed employees to move more quickly to weave AI into their work and future products.
'All of us are using AI in a significant way already, and we must use it as a company as well,' Cook said. 'To not do so would be to be left behind, and we can't do that.'
Employees should push to deploy AI tools faster, and urge their managers and service and support teams to do the same, he said.
Cook also addressed the company's retail strategy, stressing that the current plan is to focus on opening new stores in emerging markets and upping the investment in Apple's online store. The iPhone maker is opening outlets in India, the United Arab Emirates and China this year, and is preparing to add its first location in Saudi Arabia next year.
'We need to be in more countries, and you'll see us go into more emerging markets in particular,' Cook said. That doesn't mean Apple will ignore other places, he said, but a 'disproportionate amount of growth' will be in new areas.
The CEO also shared his enthusiasm about upcoming products, though he didn't get specific. 'I have never felt so much excitement and so much energy before as right now,' he said.
Bloomberg News has previously reported that Apple plans to launch its first foldable iPhone next year and is also working on a stream of smart home devices. New headset products, smart glasses, a push into robotics and a redesigned iPhone for the two-decade anniversary are also underway.
'The product pipeline, which I can't talk about: It's amazing, guys. It's amazing,' Cook said. 'Some of it you'll see soon, some of it will come later, but there's a lot to see.'
How Podcast-Obsessed Tech Investors Made a New Media Industry
Russia Builds a New Web Around Kremlin's Handpicked Super App
Everyone Loves to Hate Wind Power. Scotland Found a Way to Make It Pay Off
It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan
Cage-Free Eggs Are Booming in the US, Despite Cost and Trump's Efforts
©2025 Bloomberg L.P.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pharma interest can plug NIH funding gap: Illumina CEO
Pharma interest can plug NIH funding gap: Illumina CEO

Yahoo

time14 minutes ago

  • Yahoo

Pharma interest can plug NIH funding gap: Illumina CEO

Genetic sequencing company Illumina (ILMN) has had a rough few years. It has battled activist investors, faced off with the Federal Trade Commission, and, most recently, agreed to a $9.8 million settlement with the Department of Justice over a cybersecurity breach. To add to the pile: sanctions in China and the Trump administration cutting National Institutes of Health (NIH) funding, which the company relies heavily on for clinical research. The numbers don't lie. The stock is down more than 21% in the past year and sank more than 11% in after-hours trading Thursday after the company reported an earnings miss for the second quarter. The company reported $1.06 billion in revenues compared to expected revenues of $1.05 billion. Adjusted earnings per share came in at $1.19 compared to estimates of $1.01. But CEO Jacob Thaysen told Yahoo Finance he remains positive about the company's near-term growth. Why? Because, in part, pharmaceutical companies can provide a new market. "Now, we're shifting from small things to really big programs. Some of the things making up for the reduction from the NIH is kind of indirect, but pharma is getting more interest in these big programs," he said, noting that 15% of the company is exposed to government research funding. "It's not only about sequencing itself, but really using massive amounts of data ... to really identify new drug targets and understand a disease," Thaysen said. The idea to use patient data to help the pharmaceutical world was also identified by 23andMe, which recently came out of bankruptcy through a nonprofit led by founder Anne Wojcicki. Thaysen said that unlike 23andMe, which he has worked with, his company is not going to pursue drug development on its own. "We have a lot of pharma companies that are very excited to work with us," he said. In addition to genetic testing of patient samples, the company is looking at growing in the preventative side of care with cancer screenings. The oncology business, Thaysen said, will have healthy growth over the next 10 or so years. China China banned importations of the San Diego-based company's sequencing machines earlier this year as part of its retaliatory actions to Trump's tariff war. Thaysen said he is working with regulators to try to reverse that, but "in the meantime, that business is declining, and we are expecting it to be flat." In fact, though China has historically been about 10% of the company's business, it contributed to half of the decline in earnings this past week. "China was never a huge part of Illumina's business. When it was the largest, it was just around 10%. We're down to 5% of the business," Thaysen told Yahoo Finance. But because of the tariff war and China's goals to boost its domestic innovation market, Illumina has faced a setback in its market power there from local competition. "As soon as there is a Chinese alternative that is good enough, then you will see that the Chinese government is pushing for the Chinese population, the Chinese companies to use that technology," Thaysen said. He added that even with the increased competition, China is an appealing market to remain in. Analysts are still waiting to see more progress on Illumina's return to growth. Jefferies analyst Tycho Peterson said in a note to clients that the firm will reiterate its Hold rating until things settle: "While the clinical traction is encouraging, we view clarity on near-term headwinds (A&G, China, Roche) and a path to sustainable HSD growth as key to a more constructive view. Reiterate Hold." Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Lucid Group, Inc. (LCID) Opens Phoenix Hub, Accelerates Gravity SUV Production and Job Growth
Lucid Group, Inc. (LCID) Opens Phoenix Hub, Accelerates Gravity SUV Production and Job Growth

Yahoo

time14 minutes ago

  • Yahoo

Lucid Group, Inc. (LCID) Opens Phoenix Hub, Accelerates Gravity SUV Production and Job Growth

We recently compiled a list of the 10 Best Low Cost Stocks To Buy Under $50. Lucid Group, Inc. stands tenth on our list. Lucid Group, Inc. (NASDAQ:LCID) is among the cheap stocks to buy. It is a U.S.-based luxury EV manufacturer known for its Lucid Air sedan and is expanding its footprint with the upcoming Gravity SUV and a growing emphasis on advanced technology. The company operates high-tech manufacturing facilities in Arizona and focuses on performance, efficiency, and premium features. In July 2025, Lucid Group, Inc. (NASDAQ:LCID) launched key updates to its DreamDrive Pro driver-assistance system, including new hands-free driving and automated lane change features. These enhancements, delivered via over-the-air updates, place the company among leaders in driving automation and align with its long-term push toward autonomous capabilities. The corporation also announced that Air owners will gain access to Tesla's Supercharger network starting July 31, 2025, through a NACS adapter. This dramatically improves charging accessibility for LCID drivers and addresses a core challenge for EV adoption. The business expanded its manufacturing capacity with the opening of the Phoenix Hub, acquired from Nikola Corporation. This facility will support the production of the Gravity SUV and a future midsize EV platform, and is expected to create up to 500 jobs over the next few years. On the supply chain front, Lucid Group, Inc. (NASDAQ:LCID) partnered with critical mineral producers to strengthen sourcing resilience and support sustainable vehicle production in the U.S. Looking ahead, the company is ramping up Gravity SUV production and plans a 1:10 reverse stock split aimed at attracting a broader investor base. Additionally, a new marketing campaign featuring actor Timothée Chalamet will debut in fall 2025, reinforcing the corporation's image as a premium, innovative brand. While we acknowledge the potential of LCID as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

Northern Trust Second Quarter 2025 Earnings: Beats Expectations
Northern Trust Second Quarter 2025 Earnings: Beats Expectations

Yahoo

time14 minutes ago

  • Yahoo

Northern Trust Second Quarter 2025 Earnings: Beats Expectations

Northern Trust (NASDAQ:NTRS) Second Quarter 2025 Results Key Financial Results Revenue: US$1.98b (down 27% from 2Q 2024). Net income: US$412.8m (down 53% from 2Q 2024). Profit margin: 21% (down from 33% in 2Q 2024). The decrease in margin was driven by lower revenue. EPS: US$2.14 (down from US$4.35 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Northern Trust Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 4.2%. Looking ahead, revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Capital Markets industry in the US. Performance of the American Capital Markets industry. The company's shares are down 2.3% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Northern Trust. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store